Diclofenac shouldn’t be prescribed to people with heart problems, drug agency says
BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4285 (Published 02 July 2013) Cite this as: BMJ 2013;347:f4285- Jacqui Wise
- 1London
Diclofenac should not be prescribed to patients with serious underlying heart conditions because of a small increased risk of heart attack and stroke, the UK Medicines and Healthcare Products Regulatory Agency has warned.1
The advice comes after a recent meta-analysis found that the arterial thrombotic risk with diclofenac was similar to that with the selective cyclo-oxygenase-2 (COX-2) inhibitors.2 The study found that, in comparison with placebo, the risk of major vascular events was increased by about a third by a COX-2 inhibitor (rate ratio 1.4 (95% confidence interval …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.